Amishi Bajaj

Amishi Bajaj

Auto-generated profile, based on publicly available information

Amishi Bajaj

Northwestern University, Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
ABAmishi Bajaj
Amishi Bajaj
BMBrendan Martin
Brendan Martin
RBRicha Bhasin
Richa Bhasin
CHCourtney Hentz
Courtney Hentz
ABAlec M. Block
Alec M. Block
ASAbhishek Ashok Solanki
Abhishek Ashok Solanki

1 February 2018 in Gynecologic Oncology Reports
Verified
Journal Article
Open access
ABAmishi Bajaj
Amishi Bajaj
MGMahesh Gopalakrishnan
Mahesh Gopalakrishnan
MHMatthew M. Harkenrider
Matthew M. Harkenrider
JLJohn R. Lurain
John R. Lurain
WSWilliam C. Small
William C. Small
The purpose of this article is to present a case of successful treatment of a patient with stage IVB small cell carcinoma of the cervix (SCCC) who was treated with concurrent chemoradiotherapy (CCRT) consisting of etoposide/cisplatin (EP) chemotherapy, external beam radiation therapy (EBRT), and brachytherapy. The patient has since remained without evidence of disease for nearly six years. This report reviews and summarizes the existing case literature on SCCC.

1 August 2021 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PDF file
ABAmishi Bajaj
Amishi Bajaj
IDIndra J. Das
Indra J. Das

Indra J DasIndra J Das
Indra J Das
JKJohn A. Kalapurakal
John A. Kalapurakal
JSJonathan B. Strauss
Jonathan B. Strauss
BZBrian R. Zawislak
Brian R. Zawislak
MGMahesh Gopalakrishnan
Mahesh Gopalakrishnan
BMBharat B. Mittal
Bharat B. Mittal
Background: A comprehensive response to the unprecedented SARS-CoV-2 (COVID-19) challenges for public health and its impact on radiation oncology patients and personnel for resilience and adaptability is presented. Methods: The general recommendations included working remotely when feasible, implementation of screening/safety and personal protective equipment (PPE) guidelines, social distancing, regular cleaning of treatment environment, and testing for high-risk patients/procedures. All teaching conferences, tumor boards, and weekly chart rounds were conducted using a virtual platform. Additionally, specific recommendations were given to each section to ensure proper patient treatments. The impact of these measures, especially adaptability and resilience, were evaluated through specific questionnaire surveys. Results: These comprehensive COVID-19-related measures resulted in most staff expressing a consistent level of satisfaction in regard to personal safety, maintaining a safe work environment, continuing quality patient care, and continuing educational activities during the pandemic. There was a significant reduction in patient treatments and on-site patient visits with an appreciable increase in the number of telemedicine e-visits. Conclusions: Survey results demonstrated substantial adaptability and resilience, including in the rapid recovery of departmental activities during the reactivation phase. In the event of a future public health emergency, the measures implemented may be adopted with good outcomes by radiation oncology departments across the globe.

3 December 2021 in Advances in Radiation Oncology
Verified
Journal Article
Open access
ABAmishi Bajaj
Amishi Bajaj
LALaura L. Ashack
Laura L. Ashack

27 October 2022
Verified
Book Chapter
Closed access
PDF file
ABAmishi Bajaj
Amishi Bajaj
HSHina Saeed
Hina Saeed